+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

In Vitro Diagnostics Market by Product & Service, Technique, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2022 - 2030

  • PDF Icon

    Report

  • 690 Pages
  • July 2022
  • Region: Global
  • Next Move Strategy Consulting
  • ID: 5633400

At an estimated value of over USD 86.51 billion in 2021, the Global In Vitro Diagnostics (IVD) Market is predicted to thrive at a CAGR of 3.3% and valued at over USD 118.57 billion over the forecast year 2022-2030. In vitro diagnostics (IVD) are the tests for detecting disease and infections. It is done on samples such as tissue or blood taken from the human body. There are several types of in vitro diagnostic instruments that offers features such as tissue diagnostics, hematology, immunodiagnostics, and molecular diagnostics. The in vitro diagnostics is experiencing a significant popularity in healthcare sector due to its efficacy in diagnosing numerous medical conditions such as infectious diseases, cardiac disorders, cancer, and nephrological disorders.

Market Dynamics and Trends


Upsurge in number of in vitro diagnostic tests across the globe owing to the increased incidences of infectious and chronic diseases drives the growth of IVD market. In addition, rise in geriatric population, which is vulnerable to immunological disorders have been pushing the growth of the market globally. However, strict government regulations related to the in-vitro diagnostics along with unfavorable compensation policies hamper the growth of the market. On the other hand, high growth shown by the developing countries in terms of population & proliferation of in vitro diagnostic tests is expected to create lucrative opportunities to further propel market growth throughout the forecast period.


Market Segmentations and Scope of the Study:


The global In vitro diagnostics (IVD) market share is segmented on the basis of product & service, technique, application, end user, and geography. On the basis of product & service, the market is categorized into Instruments, Reagents, and Software & Services. According to the technique, the market is segmented into immunodiagnostics, hematology, molecular diagnostics, clinical chemistry, tissue diagnostics, and others. As per the application, the market is divided into infectious diseases, cancer, immune system disorders, cardiac diseases, nephrological diseases, gastrointestinal diseases, and others. On the basis of end user, the market is segmented into standalone laboratory, academic & medical schools, hospitals, point of care, and others. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.


Geographical Analysis


In terms of geography, North America held major share of the market in 2019. This is attributed to the well-established healthcare system and the healthcare related awareness among people across the region. However, Asia-pacific is expected to witness highest growth rate during the forecast period, due to the surge in healthcare expenditure and rise in prevalence of diabetes in the region. Moreover, massively growing patient base of chronic diseases in the region that require IVD testing is projected to be opportunistic for the market growth.


Competitive Landscape


Lucrative growth opportunities make the In Vitro Diagnostics (IVD) market highly competitive. Some of the major players in the market are Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, BioMérieux SA, Sysmex Corporation, Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche AG, Siemens AG, QIAGEN N.V., Thermo Fisher Scientific, Inc. and many more. A number of developmental strategies have been adopted by companies in the past few years. For instance, in October 2020, Quanterix Corporation entered into a non-exclusive royalty-bearing license agreement with Abbott Laboratories. This agreement grants Abbott an access to Quanterix’ portfolio of bead-based technology patents for the use in in vitro diagnostic (IVD) applications.


KEY MARKET SEGMENTS:


Global In Vitro Diagnostics (IVD) Market- By Product & Service

  • Instruments
  • Reagents
  • Software & Services

Global In Vitro Diagnostics (IVD) Market - By Technique

  • Immunodiagnostics
  • Enzyme-linked immunosorbent assay (ELISA)
  • Rapid Tests
  • Enzyme-linked immunospot (ELISPOT)
  • Radioimmunoassay (RIA)
  • Western blot
  • Hematology
  • Molecular Diagnostics
  • Polymerize chain reaction (PCR)
  • Isothermal Nucleic acid amplification technology (INAAT)
  • Hybridization
  • DNA diagnostics
  • Microarray
  • Others
  • Clinical Chemistry
  • Basic metabolic panel
  • Liver panel
  • Renal profile
  • Lipid profile
  • Thyroid function panel
  • Electrolyte panel
  • Specialty chemicals
  • Tissue Diagnostics
  • Others

Global In Vitro Diagnostics (IVD) Market - By Application

  • Infectious Diseases
  • Cancer
  • Immune System Disorders
  • Cardiac Diseases
  • Nephrological Diseases
  • Gastrointestinal Diseases
  • Others

Global In Vitro Diagnostics (IVD) Market - By End User

  • Standalone Laboratory
  • Academic & Medical Schools
  • Hospitals
  • Point of Care
  • Others

Global In Vitro Diagnostics (IVD) Market - By Geography

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • RoW
  • Latin America
  • Middle East
  • Africa
Frequently Asked Questions about the In Vitro Diagnostics Market

What is the estimated value of the In Vitro Diagnostics Market?

The In Vitro Diagnostics Market was estimated to be valued at $86.5 Billion in 2021.

What is the growth rate of the In Vitro Diagnostics Market?

The growth rate of the In Vitro Diagnostics Market is 3.3%, with an estimated value of $118.6 Billion by 2030.

What is the forecasted size of the In Vitro Diagnostics Market?

The In Vitro Diagnostics Market is estimated to be worth $118.6 Billion by 2030.

Who are the key companies in the In Vitro Diagnostics Market?

Key companies in the In Vitro Diagnostics Market include BioMerieux, Sysmex Corporation, Qiagen N.V., Bio Rad Laboratories Incorporation, Beckton, Dickinson & Company, Roche Holding, Abbott, Danaher Corporation, Siemens Healthineers and Thermo Fisher Scientific Inc..

Table of Contents

1. Introduction
1.1. Report Description
1.2. Who Should Read this Report
1.3. Key Market Segments
1.4. Research Methodology
1.4.1 Secondary Research
1.4.2 Data Analysis Framework
1.4.3 Market Size Estimation
1.4.4 Forecasting
1.4.5 Primary Research and Data Validation
2. in Vitro Diagnostics (Ivd) Market - Executive Summary
2.1. Market Snapshot, 2022 - 2030, Million Usd
3. Market Share Analysis, 2020 (%)
4. Market Overview
4.1. Market Definition and Scope
4.2. Market Dynamics
4.2.1 Drivers
4.2.1.1. Rising Incidences of Chronic and Infectious Diseases
4.2.1.2. Technological Advancements in Ivd
4.2.1.3. Increasing Use of Minimally Invasive Techniques
4.2.1.4. Adoption of Personalized Medicine Approach
4.2.2 Restraints
4.2.2.1. Lack of Reimbursement Policies
4.2.2.1 Stringent Regulatory Policies
4.2.3 Opportunities
4.2.3.1. Potential Opportunities for Outsourcing
4.2.3.1 Evolution in the Technologies
5. Covid-19 Analysis
6. Global in Vitro Diagnostic (Ivd) Market, by Product Type
6.1. Overview
6.2. Reagents
6.2.1 Reagents Market, by Region
6.2.1.1 North America Reagents Market, by Country
6.2.1.2 Europe Reagents Market, by Country
6.2.1.3 Asia-Pacific Reagents Market, by Country
6.2.1.4 Rest of World Reagents Market, by Country
6.3. Instruments
6.3.1 Instruments Market, by Region
6.3.1.1 North America Instruments Market, by Country
6.3.1.2 Europe Instruments Market, by Country
6.3.1.3 Asia-Pacific Instruments Market, by Country
6.3.1.4 Rest of World Instruments Market, by Country
6.4. Software and Services
6.4.1 Software and Services Market, by Region
6.4.1.1 North America Software and Services Market, by Country
6.4.1.2 Europe Software and Services Market, by Country
6.4.1.3 Asia-Pacific Software and Services Market, by Country
6.4.1.4 Rest of World Software and Services Market, by Country
7. Global in Vitro Diagnostic (Ivd) Market, by Technique
7.1. Overview
7.2. Immunodiagnostics
7.2.1 Global Immunodiagnostics Market, by Technique
7.2.1.1 Elisa Market, by Region
7.2.1.1.1 North America Elisa Market, by Country
7.2.1.1.2 Europe Elisa Market, by Country
7.2.1.1.3 Asia-Pacific Elisa Market, by Country
7.2.1.1.4 Rest of World Elisa Market, by Country
7.2.1.2 Rapid Tests Market, by Region
7.2.1.2.1 North America Rapid Tests Market, by Country
7.2.1.2.2 Europe Rapid Tests Market, by Country
7.2.1.2.3 Asia-Pacific Rapid Tests Market, by Country
7.2.1.2.4 Rest of World Rapid Tests Market, by Country
7.2.1.3 Elispot Market, by Region
7.2.1.3.1 North America Elispot Market, by Country
7.2.1.3.2 Europe Elispot Market, by Country
7.2.1.3.3 Asia-Pacific Elispot Market, by Country
7.2.1.3.4 Rest of World Elispot Market, by Country
7.2.1.4 Radioimmunoassay (Ria) Market, by Region
7.2.1.4.1 North America Radioimmunoassay (Ria) Market, by Country
7.2.1.4.2 Europe Radioimmunoassay (Ria) Market, by Country
7.2.1.4.3 Asia-Pacific Radioimmunoassay (Ria) Market, by Country
7.2.1.4.4 Rest of World Radioimmunoassay (Ria) Market, by Country
7.2.1.5 Western Blot Market, by Region
7.2.1.5.1 North America Western Blot Market, by Country
7.2.1.5.2 Europe Western Blot Market, by Country
7.2.1.5.3 Asia-Pacific Western Blot Market, by Country
7.2.1.5.4 Rest of World Western Blot Market, by Country
7.2.2 Immunodiagnostics Market, by Region
7.2.2.1 North America Immunodiagnostics Market, by Country
7.2.2.2 Europe Immunodiagnostics Market, by Country
7.2.2.3 Asia-Pacific Immunodiagnostics Market, by Country
7.2.2.4 Rest of World Immunodiagnostics Market, by Country
7.3. Hematology
7.3.1 Hematology Market, by Region
7.3.1.1 North America Hematology Market, by Country
7.3.1.2 Europe Hematology Market, by Country
7.3.1.3 Asia-Pacific Hematology Market, by Country
7.3.1.4 Rest of World Hematology Market, by Country
7.4. Molecular Diagnostics
7.4.1 Global Molecular Diagnostics Market, by Technique
7.4.1.1 Pcr Market, by Region
7.4.1.1.1 North America Pcr Market, by Country
7.4.1.1.2 Europe Pcr Market, by Country
7.4.1.1.3 Asia-Pacific Pcr Market, by Country
7.4.1.1.4 Rest of World Pcr Market, by Country
7.4.1.2 Inaat Market, by Region
7.4.1.2.1 North America Inaat Market, by Country
7.4.1.2.2 Europe Inaat Market, by Country
7.4.1.2.3 Asia-Pacific Inaat Market, by Country
7.4.1.2.4 Rest of World Inaat Market, by Country
7.4.1.3 Hybridization Market, by Region
7.4.1.3.1 North America Hybridization Market, by Country
7.4.1.3.2 Europe Hybridization Market, by Country
7.4.1.3.3 Asia-Pacific Hybridization Market, by Country
7.4.1.3.4 Rest of World Hybridization Market, by Country
7.4.1.4 Dna Diagnostics Market, by Region
7.4.1.4.1 North America Dna Diagnostics Market, by Country
7.4.1.4.2 Europe Dna Diagnostics Market, by Country
7.4.1.4.3 Asia-Pacific Dna Diagnostics Market, by Country
7.4.1.4.4 Rest of World Dna Diagnostics Market, by Country
7.4.1.5 Microarray Market, by Region
7.4.1.5.1 North America Microarray Market, by Country
7.4.1.5.2 Europe Microarray Market, by Country
7.4.1.5.3 Asia-Pacific Microarray Market, by Country
7.4.1.5.4 Rest of World Microarray Market, by Country
7.4.1.6 Others Market, by Region
7.4.1.6.1 North America Others Market, by Country
7.4.1.6.2 Europe Others Market, by Country
7.4.1.6.3 Asia-Pacific Others Market, by Country
7.4.1.6.4 Rest of World Others Market, by Country
7.4.2 Molecular Diagnostics Market, by Region
7.4.2.1 North America Molecular Diagnostics Market, by Country
7.4.2.2 Europe Molecular Diagnostics Market, by Country
7.4.2.3 Asia-Pacific Molecular Diagnostics Market, by Country
7.4.2.4 Rest of World Molecular Diagnostics Market, by Country
7.5. Tissue Disgnostics
7.5.1 Tissue Disgnostics Market, by Region
7.5.1.1 North America Tissue Disgnostics Market, by Country
7.5.1.2 Europe Tissue Disgnostics Market, by Country
7.5.1.3 Asia-Pacific Tissue Disgnostics Market, by Country
7.5.1.4 Rest of World Tissue Disgnostics Market, by Country
7.6. Clinical Chemistry
7.6.1 Global Clinical Chemistry Market, by Technique
7.6.1.1 Basic Metabolic Panel Market, by Region
7.6.1.1.1 North America Basic Metabolic Panel Market, by Country
7.6.1.1.2 Europe Basic Metabolic Panel Market, by Country
7.6.1.1.3 Asia-Pacific Basic Metabolic Panel Market, by Country
7.6.1.1.4 Rest of World Basic Metabolic Panel Market, by Country
7.6.1.2 Liver Panel Market, by Region
7.6.1.2.1 North America Liver Panel Market, by Country
7.6.1.2.2 Europe Liver Panel Market, by Country
7.6.1.2.3 Asia-Pacific Liver Panel Market, by Country
7.6.1.2.4 Rest of World Liver Panel Market, by Country
7.6.1.3 Renal Profile Market, by Region
7.6.1.3.1 North America Renal Profile Market, by Country
7.6.1.3.2 Europe Renal Profile Market, by Country
7.6.1.3.3 Asia-Pacific Renal Profile Market, by Country
7.6.1.3.4 Rest of World Renal Profile Market, by Country
7.6.1.4 Lipid Profile Market, by Region
7.6.1.4.1 North America Lipid Profile Market, by Country
7.6.1.4.2 Europe Lipid Profile Market, by Country
7.6.1.4.3 Asia-Pacific Lipid Profile Market, by Country
7.6.1.4.4 Rest of World Lipid Profile Market, by Country
7.6.1.5 Thyroid Function Panel Market, by Region
7.6.1.5.1 North America Thyroid Function Panel Market, by Country
7.6.1.5.2 Europe Thyroid Function Panel Market, by Country
7.6.1.5.3 Asia-Pacific Thyroid Function Panel Market, by Country
7.6.1.5.4 Rest of World Thyroid Function Panel Market, by Country
7.6.1.6 Electrolyte Panel Market, by Region
7.6.1.6.1 North America Electrolyte Panel Market, by Country
7.6.1.6.2 Europe Electrolyte Panel Market, by Country
7.6.1.6.3 Asia-Pacific Electrolyte Panel Market, by Country
7.6.1.6.4 Rest of World Electrolyte Panel Market, by Country
7.6.1.7 Speciality Chemicals Market, by Region
7.6.1.7.1 North America Speciality Chemicals Market, by Country
7.6.1.7.2 Europe Speciality Chemicals Market, by Country
7.6.1.7.3 Asia-Pacific Speciality Chemicals Market, by Country
7.6.1.7.4 Rest of World Speciality Chemicals Market, by Country
7.6.2 Clinical Chemistry Market, by Region
7.6.2.1 North America Clinical Chemistry Market, by Country
7.6.2.2 Europe Clinical Chemistry Market, by Country
7.6.2.3 Asia-Pacific Clinical Chemistry Market, by Country
7.6.2.4 Rest of World Clinical Chemistry Market, by Country
7.7. Other Ivd Techniques
7.7.1 Other Ivd Techniques Market, by Region
7.7.1.1 North America Other Ivd Techniques Market, by Country
7.7.1.2 Europe Other Ivd Techniques Market, by Country
7.7.1.3 Asia-Pacific Other Ivd Techniques Market, by Country
7.7.1.4 Rest of World Other Ivd Techniques Market, by Country
8. Global in Vitro Diagnostic (Ivd) Market, by Application
8.1. Overview
8.2. Infectious Diseases
8.2.1 Infectious Diseases Market, by Region
8.2.1.1 North America Infectious Diseases Market, by Country
8.2.1.2 Europe Infectious Diseases Market, by Country
8.2.1.3 Asia-Pacific Infectious Diseases Market, by Country
8.2.1.4 Rest of World Infectious Diseases Market, by Country
8.3. Cancer
8.3.1 Cancer Market, by Region
8.3.1.1 North America Cancer Market, by Country
8.3.1.2 Europe Cancer Market, by Country
8.3.1.3 Asia-Pacific Cancer Market, by Country
8.3.1.4 Rest of World Cancer Market, by Country
8.4. Cardiac Diseases
8.4.1 Cardiac Diseases Market, by Region
8.4.1.1 North America Cardiac Diseases Market, by Country
8.4.1.2 Europe Cardiac Diseases Market, by Country
8.4.1.3 Asia-Pacific Cardiac Diseases Market, by Country
8.4.1.4 Rest of World Cardiac Diseases Market, by Country
8.5. Immune System Disorders
8.5.1 Immune System Disorders Market, by Region
8.5.1.1 North America Immune System Disorders Market, by Country
8.5.1.2 Europe Immune System Disorders Market, by Country
8.5.1.3 Asia-Pacific Immune System Disorders Market, by Country
8.5.1.4 Rest of World Immune System Disorders Market, by Country
8.6. Nephrological Diseases
8.6.1 Nephrological Diseases Market, by Region
8.6.1.1 North America Nephrological Diseases Market, by Country
8.6.1.2 Europe Nephrological Diseases Market, by Country
8.6.1.3 Asia-Pacific Nephrological Diseases Market, by Country
8.6.1.4 Rest of World Nephrological Diseases Market, by Country
8.7. Gastrointestinal Diseases
8.7.1 Gastrointestinal Diseases Market, by Region
8.7.1.1 North America Gastrointestinal Diseases Market, by Country
8.7.1.2 Europe Gastrointestinal Diseases Market, by Country
8.7.1.3 Asia-Pacific Gastrointestinal Diseases Market, by Country
8.7.1.4 Rest of World Gastrointestinal Diseases Market, by Country
8.8. Other Indications
8.8.1 Other Indications Market, by Region
8.8.1.1 North America Other Indications Market, by Country
8.8.1.2 Europe Other Indications Market, by Country
8.8.1.3 Asia-Pacific Other Indications Market, by Country
8.8.1.4 Rest of World Other Indications Market, by Country
9. Global in Vitro Diagnostic (Ivd) Market, by Enduser
9.1. Overview
9.2. Stand Alone Laboratory
9.2.1 Stand Alone Laboratory Market, by Region
9.2.1.1 North America Stand Alone Laboratory Market, by Country
9.2.1.2 Europe Stand Alone Laboratory Market, by Country
9.2.1.3 Asia-Pacific Stand Alone Laboratory Market, by Country
9.2.1.4 Rest of World Stand Alone Laboratory Market, by Country
9.3. Hospitals
9.3.1 Hospitals Market, by Region
9.3.1.1 North America Hospitals Market, by Country
9.3.1.2 Europe Hospitals Market, by Country
9.3.1.3 Asia-Pacific Hospitals Market, by Country
9.3.1.4 Rest of World Hospitals Market, by Country
9.4. Academics and Medical Schools
9.4.1 Academics and Medical Schools Market, by Region
9.4.1.1 North America Academics and Medical Schools Market, by Country
9.4.1.2 Europe Academics and Medical Schools Market, by Country
9.4.1.3 Asia-Pacific Academics and Medical Schools Market, by Country
9.4.1.4 Rest of World Academics and Medical Schools Market, by Country
9.5. Point of Care Testing
9.5.1 Point of Care Testing Market, by Region
9.5.1.1 North America Point of Care Testing Market, by Country
9.5.1.2 Europe Point of Care Testing Market, by Country
9.5.1.3 Asia-Pacific Point of Care Testing Market, by Country
9.5.1.4 Rest of World Point of Care Testing Market, by Country
9.6. Others
9.6.1 Others Market, by Region
9.6.1.1 North America Others Market, by Country
9.6.1.2 Europe Others Market, by Country
9.6.1.3 Asia-Pacific Others Market, by Country
9.6.1.4 Rest of World Others Market, by Country
10. Global in Vitro Diagnostic (Ivd) Market, by Region
10.1. Overview
10.2. North America
10.2.1 North America in Vitro Diagnostic (Ivd) Market, by Product Type
10.2.2 North America in Vitro Diagnostic (Ivd) Market, by Technique
10.2.2.1 North America Immunodiagnostics Market, by Technique
10.2.2.2 North America Molecular Diagnostics Market, by Technique
10.2.2.3 North America Clinical Chemistry Market, by Technique
10.2.3 North America in Vitro Diagnostic (Ivd) Market, by Application
10.2.4 North America in Vitro Diagnostic (Ivd) Market, by Enduser
10.2.5 North America in Vitro Diagnostic (Ivd) Market, by Country
10.2.5.1 U.S.
10.2.5.1.1 U.S. in Vitro Diagnostic (Ivd) Market, by Product Type
10.2.5.1.2 U.S. in Vitro Diagnostic (Ivd) Market, by Technique
10.2.5.1.2.1. U.S. Immunodiagnostics Market, by Technique
10.2.5.1.2.2. U.S. Molecular Diagnostics Market, by Technique
10.2.5.1.2.3. U.S. Clinical Chemistry Market, by Technique
10.2.5.1.3 U.S. in Vitro Diagnostic (Ivd) Market, by Application
10.2.5.1.4 U.S. in Vitro Diagnostic (Ivd) Market, by Enduser
10.2.5.2 Canada
10.2.5.2.1 Canada in Vitro Diagnostic (Ivd) Market, by Product Type
10.2.5.2.2 Canada in Vitro Diagnostic (Ivd) Market, by Technique
10.2.5.2.2.1. Canada Immunodiagnostics Market, by Technique
10.2.5.2.2.2. Canada Molecular Diagnostics Market, by Technique
10.2.5.2.2.3. Canada Clinical Chemistry Market, by Technique
10.2.5.2.3 Canada in Vitro Diagnostic (Ivd) Market, by Application
10.2.5.2.4 Canada in Vitro Diagnostic (Ivd) Market, by Enduser
10.2.5.3 Mexico
10.2.5.3.1 Mexico in Vitro Diagnostic (Ivd) Market, by Product Type
10.2.5.3.2 Mexico in Vitro Diagnostic (Ivd) Market, by Technique
10.2.5.3.2.1. Mexico Immunodiagnostics Market, by Technique
10.2.5.3.2.2. Mexico Molecular Diagnostics Market, by Technique
10.2.5.3.2.3. Mexico Clinical Chemistry Market, by Technique
10.2.5.3.3 Mexico in Vitro Diagnostic (Ivd) Market, by Application
10.2.5.3.4 Mexico in Vitro Diagnostic (Ivd) Market, by Enduser
10.3. Europe
10.3.1 Europe in Vitro Diagnostic (Ivd) Market, by Product Type
10.3.2 Europe in Vitro Diagnostic (Ivd) Market, by Technique
10.3.2.1 Europe Immunodiagnostics Market, by Technique
10.3.2.2 Europe Molecular Diagnostics Market, by Technique
10.3.2.3 Europe Clinical Chemistry Market, by Technique
10.3.3 Europe in Vitro Diagnostic (Ivd) Market, by Application
10.3.4 Europe in Vitro Diagnostic (Ivd) Market, by Enduser
10.3.5 Europe in Vitro Diagnostic (Ivd) Market, by Country
10.3.5.1 Germany
10.3.5.1.1 Germany in Vitro Diagnostic (Ivd) Market, by Product Type
10.3.5.1.2 Germany in Vitro Diagnostic (Ivd) Market, by Technique
10.3.5.1.2.1. Germany Immunodiagnostics Market, by Technique
10.3.5.1.2.2. Germany Molecular Diagnostics Market, by Technique
10.3.5.1.2.3. Germany Clinical Chemistry Market, by Technique
10.3.5.1.3 Germany in Vitro Diagnostic (Ivd) Market, by Application
10.3.5.1.4 Germany in Vitro Diagnostic (Ivd) Market, by Enduser
10.3.5.2 France
10.3.5.2.1 France in Vitro Diagnostic (Ivd) Market, by Product Type
10.3.5.2.2 France in Vitro Diagnostic (Ivd) Market, by Technique
10.3.5.2.2.1. France Immunodiagnostics Market, by Technique
10.3.5.2.2.2. France Molecular Diagnostics Market, by Technique
10.3.5.2.2.3. France Clinical Chemistry Market, by Technique
10.3.5.2.3 France in Vitro Diagnostic (Ivd) Market, by Application
10.3.5.2.4 France in Vitro Diagnostic (Ivd) Market, by Enduser
10.3.5.3 UK
10.3.5.3.1 UK in Vitro Diagnostic (Ivd) Market, by Product Type
10.3.5.3.2 UK in Vitro Diagnostic (Ivd) Market, by Technique
10.3.5.3.2.1. UK Immunodiagnostics Market, by Technique
10.3.5.3.2.2. UK Molecular Diagnostics Market, by Technique
10.3.5.3.2.3. UK Clinical Chemistry Market, by Technique
10.3.5.3.3 UK in Vitro Diagnostic (Ivd) Market, by Application
10.3.5.3.4 UK in Vitro Diagnostic (Ivd) Market, by Enduser
10.3.5.4 Italy
10.3.5.4.1 Italy in Vitro Diagnostic (Ivd) Market, by Product Type
10.3.5.4.2 Italy in Vitro Diagnostic (Ivd) Market, by Technique
10.3.5.4.2.1. Italy Immunodiagnostics Market, by Technique
10.3.5.4.2.2. Italy Molecular Diagnostics Market, by Technique
10.3.5.4.2.3. Italy Clinical Chemistry Market, by Technique
10.3.5.4.3 Italy in Vitro Diagnostic (Ivd) Market, by Application
10.3.5.4.4 Italy in Vitro Diagnostic (Ivd) Market, by Enduser
10.3.5.5 Spain
10.3.5.5.1 Spain in Vitro Diagnostic (Ivd) Market, by Product Type
10.3.5.5.2 Spain in Vitro Diagnostic (Ivd) Market, by Technique
10.3.5.5.2.1. Spain Immunodiagnostics Market, by Technique
10.3.5.5.2.2. Spain Molecular Diagnostics Market, by Technique
10.3.5.5.2.3. Spain Clinical Chemistry Market, by Technique
10.3.5.5.3 Spain in Vitro Diagnostic (Ivd) Market, by Application
10.3.5.5.4 Spain in Vitro Diagnostic (Ivd) Market, by Enduser
10.3.5.6 Rest of Europe
10.3.5.6.1 Rest of Europe in Vitro Diagnostic (Ivd) Market, by Product Type
10.3.5.6.2 Rest of Europe in Vitro Diagnostic (Ivd) Market, by Technique
10.3.5.6.2.1. Rest of Europe Immunodiagnostics Market, by Technique
10.3.5.6.2.2. Rest of Europe Molecular Diagnostics Market, by Technique
10.3.5.6.2.3. Rest of Europe Clinical Chemistry Market, by Technique
10.3.5.6.3 Rest of Europe in Vitro Diagnostic (Ivd) Market, by Application
10.3.5.6.4 Rest of Europe in Vitro Diagnostic (Ivd) Market, by Enduser
10.4. Asia-Pacific
10.4.1 Asia-Pacific in Vitro Diagnostic (Ivd) Market, by Product Type
10.4.2 Asia-Pacific in Vitro Diagnostic (Ivd) Market, by Technique
10.4.2.1 Asia-Pacific Immunodiagnostics Market, by Technique
10.4.2.2 Asia-Pacific Molecular Diagnostics Market, by Technique
10.4.2.3 Asia-Pacific Clinical Chemistry Market, by Technique
10.4.3 Asia-Pacific in Vitro Diagnostic (Ivd) Market, by Application
10.4.4 Asia-Pacific in Vitro Diagnostic (Ivd) Market, by Enduser
10.4.5 Asia-Pacific in Vitro Diagnostic (Ivd) Market, by Country
10.4.5.1 India
10.4.5.1.1 India in Vitro Diagnostic (Ivd) Market, by Product Type
10.4.5.1.2 India in Vitro Diagnostic (Ivd) Market, by Technique
10.4.5.1.2.1. India Immunodiagnostics Market, by Technique
10.4.5.1.2.2. India Molecular Diagnostics Market, by Technique
10.4.5.1.2.3. India Clinical Chemistry Market, by Technique
10.4.5.1.3 India in Vitro Diagnostic (Ivd) Market, by Application
10.4.5.1.4 India in Vitro Diagnostic (Ivd) Market, by Enduser
10.4.5.2 China
10.4.5.2.1 China in Vitro Diagnostic (Ivd) Market, by Product Type
10.4.5.2.2 China in Vitro Diagnostic (Ivd) Market, by Technique
10.4.5.2.2.1. China Immunodiagnostics Market, by Technique
10.4.5.2.2.2. China Molecular Diagnostics Market, by Technique
10.4.5.2.2.3. China Clinical Chemistry Market, by Technique
10.4.5.2.3 China in Vitro Diagnostic (Ivd) Market, by Application
10.4.5.2.4 China in Vitro Diagnostic (Ivd) Market, by Enduser
10.4.5.3 Japan
10.4.5.3.1 Japan in Vitro Diagnostic (Ivd) Market, by Product Type
10.4.5.3.2 Japan in Vitro Diagnostic (Ivd) Market, by Technique
10.4.5.3.2.1. Japan Immunodiagnostics Market, by Technique
10.4.5.3.2.2. Japan Molecular Diagnostics Market, by Technique
10.4.5.3.2.3. Japan Clinical Chemistry Market, by Technique
10.4.5.3.3 Japan in Vitro Diagnostic (Ivd) Market, by Application
10.4.5.3.4 Japan in Vitro Diagnostic (Ivd) Market, by Enduser
10.4.5.4 Australia
10.4.5.4.1 Australia in Vitro Diagnostic (Ivd) Market, by Product Type
10.4.5.4.2 Australia in Vitro Diagnostic (Ivd) Market, by Technique
10.4.5.4.2.1. Australia Immunodiagnostics Market, by Technique
10.4.5.4.2.2. Australia Molecular Diagnostics Market, by Technique
10.4.5.4.2.3. Australia Clinical Chemistry Market, by Technique
10.4.5.4.3 Australia in Vitro Diagnostic (Ivd) Market, by Application
10.4.5.4.4 Australia in Vitro Diagnostic (Ivd) Market, by Enduser
10.4.5.5 South Korea
10.4.5.5.1 South Korea in Vitro Diagnostic (Ivd) Market, by Product Type
10.4.5.5.2 South Korea in Vitro Diagnostic (Ivd) Market, by Technique
10.4.5.5.2.1. South Korea Immunodiagnostics Market, by Technique
10.4.5.5.2.2. South Korea Molecular Diagnostics Market, by Technique
10.4.5.5.2.3. South Korea Clinical Chemistry Market, by Technique
10.4.5.5.3 South Korea in Vitro Diagnostic (Ivd) Market, by Application
10.4.5.5.4 South Korea in Vitro Diagnostic (Ivd) Market, by Enduser
10.4.5.6 Rest of Asia-Pacific
10.4.5.6.1 Rest of Asia-Pacific in Vitro Diagnostic (Ivd) Market, by Product Type
10.4.5.6.2 Rest of Asia-Pacific in Vitro Diagnostic (Ivd) Market, by Technique
10.4.5.6.2.1. Rest of Asia-Pacific Immunodiagnostics Market, by Technique
10.4.5.6.2.2. Rest of Asia-Pacific Molecular Diagnostics Market, by Technique
10.4.5.6.2.3. Rest of Asia-Pacific Clinical Chemistry Market, by Technique
10.4.5.6.3 Rest of Asia-Pacific in Vitro Diagnostic (Ivd) Market, by Application
10.4.5.6.4 Rest of Asia-Pacific in Vitro Diagnostic (Ivd) Market, by Enduser
10.5. Rest of World
10.5.1 Rest of World in Vitro Diagnostic (Ivd) Market, by Product Type
10.5.2 Rest of World in Vitro Diagnostic (Ivd) Market, by Technique
10.5.2.1 Rest of World Immunodiagnostics Market, by Technique
10.5.2.2 Rest of World Molecular Diagnostics Market, by Technique
10.5.2.3 Rest of World Clinical Chemistry Market, by Technique
10.5.3 Rest of World in Vitro Diagnostic (Ivd) Market, by Application
10.5.4 Rest of World in Vitro Diagnostic (Ivd) Market, by Enduser
10.5.5 Rest of World in Vitro Diagnostic (Ivd) Market, by Country
10.5.5.1 Latin America
10.5.5.1.1 Latin America in Vitro Diagnostic (Ivd) Market, by Product Type
10.5.5.1.2 Latin America in Vitro Diagnostic (Ivd) Market, by Technique
10.5.5.1.2.1. Latin America Immunodiagnostics Market, by Technique
10.5.5.1.2.2. Latin America Molecular Diagnostics Market, by Technique
10.5.5.1.2.3. Latin America Clinical Chemistry Market, by Technique
10.5.5.1.3 Latin America in Vitro Diagnostic (Ivd) Market, by Application
10.5.5.1.4 Latin America in Vitro Diagnostic (Ivd) Market, by Enduser
10.5.5.2 Middle East
10.5.5.2.1 Middle East in Vitro Diagnostic (Ivd) Market, by Product Type
10.5.5.2.2 Middle East in Vitro Diagnostic (Ivd) Market, by Technique
10.5.5.2.2.1. Middle East Immunodiagnostics Market, by Technique
10.5.5.2.2.2. Middle East Molecular Diagnostics Market, by Technique
10.5.5.2.2.3. Middle East Clinical Chemistry Market, by Technique
10.5.5.2.3 Middle East in Vitro Diagnostic (Ivd) Market, by Application
10.5.5.2.4 Middle East in Vitro Diagnostic (Ivd) Market, by Enduser
10.5.5.3 Africa
10.5.5.3.1 Africa in Vitro Diagnostic (Ivd) Market, by Product Type
10.5.5.3.2 Africa in Vitro Diagnostic (Ivd) Market, by Technique
10.5.5.3.2.1. Africa Immunodiagnostics Market, by Technique
10.5.5.3.2.2. Africa Molecular Diagnostics Market, by Technique
10.5.5.3.2.3. Africa Clinical Chemistry Market, by Technique
10.5.5.3.3 Africa in Vitro Diagnostic (Ivd) Market, by Application
10.5.5.3.4 Africa in Vitro Diagnostic (Ivd) Market, by Enduser
11. Company Profiles
11.1. Biomerieux
11.1.1 Company Overview
11.1.2 Company Snapshot
11.1.3 Operating Business Segments
11.1.4 Business Performance
11.1.5 Sales by Business Segment
11.1.6 Sales by Geographic Segment
11.1.7 Key Strategic Moves & Developments
11.1.8 Primary Market Competitors
11.2. Sysmex Corporation
11.2.1 Company Overview
11.2.2 Company Snapshot
11.2.3 Operating Business Segments
11.2.4 Business Performance
11.2.5 Sales by Geographic Segment
11.2.6 Key Strategic Moves & Developments
11.2.7 Primary Market Competitors
11.3. Qiagen N.V.
11.3.1 Company Overview
11.3.2 Company Snapshot
11.3.3 Operating Business Segments
11.3.4 Business Performance
11.3.5 Sales by Business Segment
11.3.6 Sales by Geographic Segment
11.3.7 Key Strategic Moves & Developments
11.3.8 Primary Market Competitors
11.4. Bio-Rad Laboratories, Inc.
11.4.1 Company Overview
11.4.2 Company Snapshot
11.4.3 Operating Business Segments
11.4.4 Business Performance
11.4.5 Sales by Business Segment
11.4.6 Sales by Geographic Segment
11.4.7 Key Strategic Moves & Developments
11.4.8 Primary Market Competitors
11.5. Becton, Dickinson and Company
11.5.1 Company Overview
11.5.2 Company Snapshot
11.5.3 Operating Business Segments
11.5.4 Business Performance
11.5.5 Sales by Business Segment
11.5.6 Sales by Geographic Segment
11.5.7 Key Strategic Moves & Developments
11.5.8 Primary Market Competitors
11.6. Roche Holding
11.6.1 Company Overview
11.6.2 Company Snapshot
11.6.3 Operating Business Segments
11.6.4 Business Performance
11.6.5 Sales by Business Segment
11.6.6 Sales by Geographic Segment
11.6.7 Key Strategic Moves & Developments
11.6.8 Primary Market Competitors
11.7. Abbott
11.7.1 Company Overview
11.7.2 Company Snapshot
11.7.3 Operating Business Segments
11.7.4 Business Performance
11.7.5 Sales by Business Segment
11.7.6 Sales by Geographic Segment
11.7.7 Key Strategic Moves & Developments
11.7.8 Primary Market Competitors
11.8. Danaher
11.8.1 Company Overview
11.8.2 Company Snapshot
11.8.3 Operating Business Segments
11.8.4 Business Performance
11.8.5 Sales by Business Segment
11.8.6 Sales by Geographic Segment
11.8.7 Key Strategic Moves & Developments
11.8.8 Primary Market Competitors
11.9. Siemens Healthineers
11.9.1 Company Overview
11.9.2 Company Snapshot
11.9.3 Operating Business Segments
11.9.4 Business Performance
11.9.5 Sales by Business Segment
11.9.6 Sales by Geographic Segment
11.9.7 Key Strategic Moves & Developments
11.9.8 Primary Market Competitors
11.10. Thermo Fisher Scientific Inc.
11.10.1 Company Overview
11.10.2 Company Snapshot
11.10.3 Operating Business Segments
11.10.4 Business Performance
11.10.5 Sales by Business Segment
11.10.6 Sales by Geographic Segment
11.10.7 Key Strategic Moves & Developments
11.10.8 Primary Market Competitors

Companies Mentioned

A selection of companies mentioned in this report includes:

  • BioMerieux
  • Sysmex Corporation
  • Qiagen N.V.
  • Bio Rad Laboratories Incorporation
  • Beckton, Dickinson & Company
  • Roche Holding
  • Abbott
  • Danaher Corporation
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.